304 related articles for article (PubMed ID: 29171144)
1. Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma.
Thompson KJ; Austin RG; Nazari SS; Gersin KS; Iannitti DA; McKillop IH
Liver Int; 2018 Jun; 38(6):1074-1083. PubMed ID: 29171144
[TBL] [Abstract][Full Text] [Related]
2. Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors.
Chiyonobu N; Shimada S; Akiyama Y; Mogushi K; Itoh M; Akahoshi K; Matsumura S; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Suganami T; Yamaoka S; Ogawa Y; Tanabe M; Tanaka S
Am J Pathol; 2018 May; 188(5):1213-1224. PubMed ID: 29454748
[TBL] [Abstract][Full Text] [Related]
3. [Study of abnormal lipid metabolism analysis and significance of fatty acid binding protein expression in patients with hepatocellular carcinoma].
Lin YX; Chen K; An FM; Wang YF; Wu XB; Zhan Q; Zhang GQ
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):1006-1013. PubMed ID: 34814397
[No Abstract] [Full Text] [Related]
4. Cytochrome P450 2E1-dependent hepatic ethanol metabolism induces fatty acid-binding protein 4 and steatosis.
Attal N; Marrero E; Thompson KJ; McKillop IH
Alcohol Clin Exp Res; 2022 Jun; 46(6):928-940. PubMed ID: 35403271
[TBL] [Abstract][Full Text] [Related]
5. FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma.
Zhong CQ; Zhang XP; Ma N; Zhang EB; Li JJ; Jiang YB; Gao YZ; Yuan YM; Lan SQ; Xie D; Cheng SQ
Cancer Med; 2018 Jun; 7(6):2629-2640. PubMed ID: 29733540
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
7. Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma.
Ku CY; Liu YH; Lin HY; Lu SC; Lin JY
Oncotarget; 2016 Apr; 7(14):18229-46. PubMed ID: 26919097
[TBL] [Abstract][Full Text] [Related]
8. Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling.
Benbow JH; Thompson KJ; Cope HL; Brandon-Warner E; Culberson CR; Bossi KL; Li T; Russo MW; Gersin KS; McKillop IH; deLemos AS; Schrum LW
Am J Pathol; 2016 Jan; 186(1):145-58. PubMed ID: 26603137
[TBL] [Abstract][Full Text] [Related]
9. Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.
Yang H; Deng Q; Ni T; Liu Y; Lu L; Dai H; Wang H; Yang W
Int J Biol Sci; 2021; 17(15):4207-4222. PubMed ID: 34803493
[No Abstract] [Full Text] [Related]
10. Fatty acid binding protein-4 promotes alcohol-dependent hepatosteatosis and hepatocellular carcinoma progression.
Attal N; Sullivan MT; Girardi CA; Thompson KJ; McKillop IH
Transl Oncol; 2021 Jan; 14(1):100975. PubMed ID: 33290990
[TBL] [Abstract][Full Text] [Related]
11. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
12. Nuclear α1-antichymotrypsin promotes chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cells.
Santamaria M; Pardo-Saganta A; Alvarez-Asiain L; Di Scala M; Qian C; Prieto J; Avila MA
Gastroenterology; 2013 Apr; 144(4):818-828.e4. PubMed ID: 23295442
[TBL] [Abstract][Full Text] [Related]
13. Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells.
Bosquet A; Guaita-Esteruelas S; Saavedra P; Rodríguez-Calvo R; Heras M; Girona J; Masana L
Atherosclerosis; 2016 Jun; 249():191-9. PubMed ID: 27155388
[TBL] [Abstract][Full Text] [Related]
14. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2.
Xu H; Hertzel AV; Steen KA; Wang Q; Suttles J; Bernlohr DA
Mol Cell Biol; 2015 Mar; 35(6):1055-65. PubMed ID: 25582199
[TBL] [Abstract][Full Text] [Related]
16. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.
Wu H; Ng R; Chen X; Steer CJ; Song G
Gut; 2016 Nov; 65(11):1850-1860. PubMed ID: 26282675
[TBL] [Abstract][Full Text] [Related]
18. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.
Uehara H; Takahashi T; Oha M; Ogawa H; Izumi K
Int J Cancer; 2014 Dec; 135(11):2558-68. PubMed ID: 24740818
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
20. Exercise retards hepatocarcinogenesis in obese mice independently of weight control.
Arfianti A; Pok S; Barn V; Haigh WG; Yeh MM; Ioannou GN; Teoh NC; Farrell GC
J Hepatol; 2020 Jul; 73(1):140-148. PubMed ID: 32302728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
